Class Notes (838,403)
Canada (510,881)
Nursing (189)
NURS 287 (31)
Lecture 4

LECTURE 4.docx

2 Pages
50 Views
Unlock Document

Department
Nursing
Course
NURS 287
Professor
Rick Nilson
Semester
Winter

Description
LECTURE 4: PERIPHERAL ARTERIAL DISEASE OF THE LOWER EXTREMITIES  PAD of the lower extremities affects the aortoiliac, femoral, popliteal, tibial, or peroneal arteries.  The classic symptom of PAD of the lower extremities is intermittent claudication, which is defined as ischemic muscle ache or pain that is precipitated by a consistent level of exercise, resolves within 10 minutes or less with rest, and is reproducible.  Paresthesia, manifested as numbness or tingling in the toes or feet, may result from nerve tissue ischemia. Gradually diminishing perfusion to neurons produces loss of both pressure and deep pain sensations.  Physical findings include thin, shiny, and taut skin; loss of hair on the lower legs; diminished or absent pedal, popliteal, or femoral pulses; pallor or blanching of the foot in response to leg elevation (elevation pallor); and reactive hyperemia (redness of the foot) when the limb is in a dependent position (dependent rubor).  Rest pain most often occurs in the forefoot or toes, is aggravated by limb elevation, and occurs when there is insufficient blood flow to maintain basic metabolic requirements of the tissues and nerves of the distal extremity.  Complications of PAD include nonhealing ulcers over bony prominences on the toes, feet, and lower leg, and gangrene. Amputation may be required if blood flow is not restored.  Tests used to diagnose PAD include Doppler ultrasound with segmental blood pressures at the thigh, below the knee, and at ankle level. A falloff in segmental BP of more than 30 mm Hg indicates PAD.  Angiography is used to delineate the location and extent of the disease process.  The first treatment goal is to aggressively modify all cardiovascular risk factors in all patients with PAD, with smoking cessation a priority.  Drug therapy includes antiplatelet agents and ACE inhibitors. Two drugs are approved to treat intermittent claudication, pentoxifylline (Trental) and cilostazol (Pletal).  The primary nonpharmacologic treatment for claudication is a formal exercise-training program with walking being the most effective exercise.  Ginkgo biloba has been found to increase walking distance for patients with intermittent claudication.  Critical limb ischemia is a chronic condition characterized by ischemic rest pain, arterial leg ulcers, and/
More Less

Related notes for NURS 287

Log In


OR

Join OneClass

Access over 10 million pages of study
documents for 1.3 million courses.

Sign up

Join to view


OR

By registering, I agree to the Terms and Privacy Policies
Already have an account?
Just a few more details

So we can recommend you notes for your school.

Reset Password

Please enter below the email address you registered with and we will send you a link to reset your password.

Add your courses

Get notes from the top students in your class.


Submit